Search

In February’s Issue of Cabot Early Opportunities we dig into the red hot IPO market.

We take a closer look at five recent IPOs that have been on my shopping list. It is not an Issue for the faint of heart. Several of these stocks have made significant moves in their short history as public companies.



There are strategies to mitigate the risks, however. And as we scan the universe of attractive stories today it is not hard to envision several of these stocks trading significantly higher a year from now.



Sit back and enjoy.

Global citizens are beginning to witness a relatively unprecedented situation in which a communicable virus that originated in China is now traveling around the globe.

By Roger Conrad in Canadian Edge: “Extendicare Real Estate Investment Trust (EXE.UN on the Toronto stock exchange or OTC in the U.S. as EXETF) has long caught my eye in the health care space as an owner and operator of long-term care facilities in the U.S....

Already the S&P500’s crisp 20% peak-to-trough drop ending on December 24th seems like a distant memory. Since last quarter, over 90% of all S&P500 stocks have advanced. Being contrarians, this prompted us to look at stocks that haven’t fully participated in the upturn.

In this issue, see the seven stocks whose shares remain well below their two-year highs, yet might have latent recovery potential.